Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of Osteoarthritis

Peng Zhao, Dong Liu, Chunying Song, Di Li, Xinzhu Zhang, Ivana Horecny, Fengqi Zhang, Yuna Yan, Linghang Zhuang, Jing Li, Suxing Liu, Yuchang Mao, Jun Feng, Jian Liu, Weikang Tao

Open source

DOI
10.1021/acsptsci.2c00023
Published
2022-06-22
Container
ACS Pharmacology & Translational Science
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsptsci.2c00023,
  title = {Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of Osteoarthritis},
  author = {Peng Zhao and Dong Liu and Chunying Song and Di Li and Xinzhu Zhang and Ivana Horecny and Fengqi Zhang and Yuna Yan and Linghang Zhuang and Jing Li and Suxing Liu and Yuchang Mao and Jun Feng and Jian Liu and Weikang Tao},
  year = {2022},
  journal = {ACS Pharmacology \& Translational Science},
  doi = {10.1021/acsptsci.2c00023},
  url = {https://doi.org/10.1021/acsptsci.2c00023}
}

RIS

TY  - JOUR
TI  - Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of Osteoarthritis
AU  - Peng Zhao
AU  - Dong Liu
AU  - Chunying Song
AU  - Di Li
AU  - Xinzhu Zhang
AU  - Ivana Horecny
AU  - Fengqi Zhang
AU  - Yuna Yan
AU  - Linghang Zhuang
AU  - Jing Li
AU  - Suxing Liu
AU  - Yuchang Mao
AU  - Jun Feng
AU  - Jian Liu
AU  - Weikang Tao
PY  - 2022
JO  - ACS Pharmacology & Translational Science
DO  - 10.1021/acsptsci.2c00023
UR  - https://doi.org/10.1021/acsptsci.2c00023
ER  - 

APA

Zhao, P., Liu, D., Song, C., Li, D., Zhang, X., Horecny, I., Zhang, F., Yan, Y., Zhuang, L., Li, J., Liu, S., Mao, Y., Feng, J., Liu, J., & Tao, W. (2022). Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of Osteoarthritis. ACS Pharmacology & Translational Science. https://doi.org/10.1021/acsptsci.2c00023

Source records